Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| InspireMD Inc New | NSPR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.94 | 07:59:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.94 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.04 - 3.85 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.94 | USD |
InspireMD Inc New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.51M | 23.46M | - | 6.21M | -19.92M | -0.85 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
InspireMD News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NSPR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.98 | 2.04 | 1.81 | 1.93 | 13,276 | -0.04 | -2.02% |
| 1 Month | 2.24 | 2.4499 | 1.81 | 2.16 | 16,824 | -0.30 | -13.39% |
| 3 Months | 2.82 | 2.89 | 1.81 | 2.28 | 35,850 | -0.88 | -31.21% |
| 6 Months | 3.39 | 3.77 | 1.81 | 2.49 | 35,899 | -1.45 | -42.77% |
| 1 Year | 1.04 | 3.85 | 1.04 | 2.54 | 64,088 | 0.90 | 86.54% |
| 3 Years | 5.12 | 6.82 | 0.8064 | 3.97 | 104,034 | -3.18 | -62.11% |
| 5 Years | 5.12 | 6.82 | 0.8064 | 3.97 | 104,034 | -3.18 | -62.11% |
InspireMD Description
| InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries. |
